Duplication of Philadelphia chromosome and trisomy of chromosome 21 in a pediatric patient with acute lymphoblastic leukemia

Keyphrases

• Duplication 100%
• Chromosome 21 100%
• Philadelphia Chromosome 100%
• Pediatric Patients 100%
• Acute Lymphoblastic Leukemia 100%
• Interphase Fluorescence in Situ Hybridization 66%
• Point mutation 66%
• FLT3 mutation 66%
• BCR-ABL Fusion Gene 66%
• Activation Loop 66%
• Polymerase Chain Reaction 66%
• Aspartate 33%
• Treatment Completion 33%
• Childhood Leukemia 33%
• Loop Domain 33%
• Prognostic Factors 33%
• Treatment Protocol 33%
• Tyrosine Kinase 33%
• FMS-like Tyrosine Kinase 3 (FLT3) 33%
• AML1 33%
• Sequence Analysis 33%
• Optimal Treatment 33%
• Chromosomal Aberrations 33%
• Tyrosine Kinase Domain 33%
• Leukemia 33%
• Subclone 33%
• Molecular Characteristics 33%
• Molecular Analysis 33%
• Tyrosine 33%
• Codon 33%
• Better Prognosis 33%
• Hyperdiploidy 33%
• Cytogenetic Analysis 33%
• Gene mutation 33%
• Neuroblastoma Cell Line 33%
• Novel Technique 33%
• Gene Duplication 33%
• Bone Marrow Samples 33%
• Line Point 33%
• Immunoglobulin Heavy Chain Gene Rearrangement 33%

Biochemistry, Genetics and Molecular Biology

• Cytogenetics 100%
• Chromosome 21 100%
• Philadelphia Chromosome 100%
• Trisomy 100%
• Interphase 66%
• Tyrosine Kinase 66%
• Fusion Gene 66%
• Fluorescence in Situ Hybridization 66%
• Receptor Tyrosine Kinase 66%
• Polymerase Chain Reaction 66%
• Point Mutation 66%
• Codon 33%
• Gene Rearrangement 33%
• Tyrosine 33%
• Aspartic Acid 33%
• Immunoglobulin Heavy Chain Gene 33%
• Gene Mutation 33%
• Chromosomal Aberration 33%
• Gene Duplication 33%
• Protein Sequencing 33%